IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$69.20 USD
-0.52 (-0.75%)
Updated Mar 28, 2024 03:59 PM ET
After-Market: $69.10 -0.10 (-0.14%) 6:52 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.33 | 0.00% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.30 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 31.82%. Look out for ITCI's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.33 per share, reflecting a year-over-year increase of 28.26%.
Earnings History
Price & Consensus
Zacks News for ITCI
Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services